Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population.
作者信息
Zeng Shuxiong, Zhang Zhensheng, Xu Chuanliang
机构信息
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
出版信息
Transl Androl Urol. 2022 Apr;11(4):573-574. doi: 10.21037/tau-2022-01.
Abstract
摘要
相似文献
1
Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population.在中国开展的基于大规模人群的上尿路尿路上皮癌研究，可能会进一步深入了解膀胱癌对中国人群中上尿路尿路上皮癌预后的影响。
Transl Androl Urol. 2022 Apr;11(4):573-574. doi: 10.21037/tau-2022-01.
2
Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.根治性手术治疗上尿路和下尿路尿路上皮癌患者的生存的部位特异性差异。
Jpn J Clin Oncol. 2021 May 28;51(6):984-991. doi: 10.1093/jjco/hyab003.
3
Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis.吸烟史与膀胱癌及上尿路上皮癌预后不良显著相关：一项荟萃分析。
J Urol. 2016 Apr;195(4 Pt 1):872-9. doi: 10.1016/j.juro.2015.10.139. Epub 2015 Oct 31.
4
Epidemiology of urothelial carcinoma.尿路上皮癌的流行病学
Int J Urol. 2017 Oct;24(10):730-734. doi: 10.1111/iju.13376. Epub 2017 May 21.
5
Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的临床意义。
Int J Urol. 2016 May;23(5):378-84. doi: 10.1111/iju.13054. Epub 2016 Jan 18.
6
Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.中国中部地区上尿路尿路上皮癌患者的预后和风险因素以及膀胱癌术后复发。
BMC Urol. 2019 Apr 18;19(1):24. doi: 10.1186/s12894-019-0457-5.
7
Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies.共聚焦激光内镜检查在膀胱和上尿路尿路上皮癌诊断中的应用：两项前瞻性探索性研究方案
JMIR Res Protoc. 2018 Feb 7;7(2):e34. doi: 10.2196/resprot.8862.
8
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States.中国与美国上尿路尿路上皮癌的临床病理特征和肿瘤学结局的多机构比较。
J Urol. 2017 May;197(5):1208-1213. doi: 10.1016/j.juro.2016.11.094. Epub 2016 Nov 22.
9
FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.FGF7 过表达是上尿路和膀胱尿路上皮癌患者的独立预后指标。
J Urol. 2015 Jul;194(1):223-9. doi: 10.1016/j.juro.2015.01.073. Epub 2015 Jan 23.
10
Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?膀胱和上尿路尿路上皮癌的分子特征的前瞻性比较——是否有生物学不一致的证据？
J Urol. 2014 Apr;191(4):926-31. doi: 10.1016/j.juro.2013.09.031. Epub 2013 Sep 20.
本文引用的文献
1
Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study.既往、同时性或膀胱内复发性膀胱癌对肾输尿管切除术后上尿路尿路上皮癌预后的影响：一项基于大人群的研究
Transl Androl Urol. 2021 Dec;10(12):4365-4375. doi: 10.21037/tau-21-758.
2
Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.马兜铃酸相关的泌尿道癌：手术风险和肿瘤学结局的最新荟萃分析以及对人类研究中观察到的分子改变的系统评价
Ther Adv Drug Saf. 2021 Mar 21;12:2042098621997727. doi: 10.1177/2042098621997727. eCollection 2021.
3
Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.马兜铃酸突变特征定义了上尿路尿路上皮癌的低危亚型。
Theranostics. 2020 Mar 4;10(10):4323-4333. doi: 10.7150/thno.43251. eCollection 2020.
4
Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后既往、同期或随后膀胱癌对预后的影响。
J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.
5
Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation.终末期肾病伴或不伴肾移植患者上尿路尿路上皮癌的倾向性匹配生存分析。
Biomed Res Int. 2019 Apr 1;2019:2979142. doi: 10.1155/2019/2979142. eCollection 2019.
6
Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy.列线图预测根治性肾输尿管切除术治疗上尿路上皮癌预后的建立与外部验证。
Urol Oncol. 2019 Apr;37(4):290.e17-290.e24. doi: 10.1016/j.urolonc.2018.12.027. Epub 2019 Jan 8.
7
Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients.含马兜铃酸的草药在上尿路尿路上皮癌患者中诱发与性别相关的肿瘤差异。
Cancer Manag Res. 2018 Dec 4;10:6627-6639. doi: 10.2147/CMAR.S178554. eCollection 2018.
8
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States.中国与美国上尿路尿路上皮癌的临床病理特征和肿瘤学结局的多机构比较。
J Urol. 2017 May;197(5):1208-1213. doi: 10.1016/j.juro.2016.11.094. Epub 2016 Nov 22.
9
Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.预测上尿路上皮癌不良病理结局的因素：来自中国一个全国性大容量中心的经验。
BJU Int. 2013 Nov;112(7):917-24. doi: 10.1111/bju.12238. Epub 2013 Jul 26.
10
CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.慢性肾脏病作为上尿路尿路上皮癌肾输尿管切除术后膀胱复发的危险因素。
Am J Kidney Dis. 2007 Nov;50(5):743-53. doi: 10.1053/j.ajkd.2007.08.007.
Zotero 插件